Maynard Um
-
-
-
-
-
-
-
Estrella Immunopharma (ESLA) Announces Activation of Additional Site for Phase I/II STARLIGHT-1 Trial
-
-
-
-
423,020 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

